ATTR-CM Third Quarter ’26 Pubs Update: Expanding Evidence, Real-World Insights & Updated Guidelines on the Role of TTR Stabilization in the DMT Era

Oct 12, 2026 | ATTR

ATTR-CM Second Quarter ’26 Pubs Update: Evolving Evidence, Disease Progression, and the Role of TTR Stabilization in the DMT Era

Jul 6, 2026 | ATTR

Update on TTR Stabilizers in ATTR-CM: New Data from ACC 2026

Apr 13, 2026 | ATTR

2) Ahmad Masri MD @MasriAhmadMD from @OHSUCardio and Martha Grogan MD @MarthaGrogan1 #cardiologist at #MayoClinic provided a similar summary after #AHA2026, which is still available for 🆓CE/#CME credit at https://t.co/AsOSdcb2PO. We keep learning more!...

ATTR-CM : Updated epidemiology, diagnosis, sex disparities and latest TTR stabilizer data from 2026 so far!

Mar 16, 2026 | ATTR

2a) This program is intended for #HCPs and is supported by an independent grant from BridgeBio. You can earn a full 1 hr of 🆓CE/#CME credit by following this 🧵!#cardioX #cardioTwitter #MedEd #ATTRCM #ATTRCMAwareness #KnowATTRCM #ATTRAmyloidosis...

Update from AHA2025 on Management of ATTR-CM With TTR Stabilizers and Other Strategies

Nov 14, 2025 | ATTR

2) We have other programs on amyloidosis still available for 🆓credit at https://t.co/41keu1YH9J; this is currently a very HOT 🔥area with both more sensitive diagnostic testing and new, highly 🎯disease-modifying therapy #DMT.#cardioX #cardiotwitter #FOAMed #MedTwitter...

Update from AHA2025: New Data on Disease Modifying Therapy in the Management of ATTR Amyloidosis

Nov 12, 2025 | ATTR

2a) Our returning expert author is @Ron_Witteles, Professor of Cardiovascular Medicine & @StanfordMedRes IM program director, specialist in #amyloidosis, #sarcoidosis, and #CardioOncology. pic.twitter.com/oPBHjWGtYh— cardio-met (@cardiomet_CE) November 13,...